These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 22186072)

  • 1. [Congenital toxoplasmosis: randomised comparison of strategies for retinochoroiditis prevention].
    Wallon M; Kieffer F; Binquet C; Thulliez P; Garcia-Méric P; Dureau P; Franck J; Peyron F; Bonnin A; Villena I; Bonithon-Kopp C; Gouyon JB; Masson S; Félin A; Cornu C
    Therapie; 2011; 66(6):473-80. PubMed ID: 22186072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors for retinochoroiditis during the first 2 years of life in infants with treated congenital toxoplasmosis.
    Kieffer F; Wallon M; Garcia P; Thulliez P; Peyron F; Franck J
    Pediatr Infect Dis J; 2008 Jan; 27(1):27-32. PubMed ID: 18162934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic problems and postnatal follow-up in congenital toxoplasmosis.
    Mazzola A; Casuccio A; Romano A; Schimmenti MG; Titone L; Di Carlo P
    Minerva Pediatr; 2007 Jun; 59(3):207-13. PubMed ID: 17519865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcome of treatment for congenital toxoplasmosis, 1981-2004: the National Collaborative Chicago-Based, Congenital Toxoplasmosis Study.
    McLeod R; Boyer K; Karrison T; Kasza K; Swisher C; Roizen N; Jalbrzikowski J; Remington J; Heydemann P; Noble AG; Mets M; Holfels E; Withers S; Latkany P; Meier P;
    Clin Infect Dis; 2006 May; 42(10):1383-94. PubMed ID: 16619149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurologic and developmental outcome in treated congenital toxoplasmosis.
    Roizen N; Swisher CN; Stein MA; Hopkins J; Boyer KM; Holfels E; Mets MB; Stein L; Patel D; Meier P
    Pediatrics; 1995 Jan; 95(1):11-20. PubMed ID: 7770286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Congenital toxoplasmosis: therapeutic strategies.
    Foulon W
    Arch Pediatr; 2003 Feb; 10 Suppl 1():10-1. PubMed ID: 12802954
    [No Abstract]   [Full Text] [Related]  

  • 7. Congenital toxoplasmosis: value of prenatal treatment with pyrimethamine-sulfadoxine combination.
    Villena I; Quereux C; Pinon JM
    Prenat Diagn; 1998 Jul; 18(7):754-6. PubMed ID: 9706662
    [No Abstract]   [Full Text] [Related]  

  • 8. Long-term outcome of children with congenital toxoplasmosis.
    Berrébi A; Assouline C; Bessières MH; Lathière M; Cassaing S; Minville V; Ayoubi JM
    Am J Obstet Gynecol; 2010 Dec; 203(6):552.e1-6. PubMed ID: 20633868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Congenital toxoplasmosis with hydrocephalus diagnosed in utero: outcome of treatment].
    Cotty F; Carpentier MA; Descamps P; Perrotin F; Richard-Lenoble D
    Arch Pediatr; 1997 Mar; 4(3):247-50. PubMed ID: 9181018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Longitudinal study of new eye lesions in treated congenital toxoplasmosis.
    Phan L; Kasza K; Jalbrzikowski J; Noble AG; Latkany P; Kuo A; Mieler W; Meyers S; Rabiah P; Boyer K; Swisher C; Mets M; Roizen N; Cezar S; Remington J; Meier P; McLeod R;
    Ophthalmology; 2008 Mar; 115(3):553-559.e8. PubMed ID: 17825418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Toxoplasmosis in childhood. Clinical findings and conclusions for medical practice].
    Geisler E; Osswald P
    Munch Med Wochenschr; 1965 Aug; 107(33):1556-67. PubMed ID: 5897871
    [No Abstract]   [Full Text] [Related]  

  • 12. [The neurologic manifestations of toxoplasmosis].
    Doutlik S; Kouba K
    Psychiatr Neurol Med Psychol (Leipz); 1974 Feb; 26(2):91-7. PubMed ID: 4842697
    [No Abstract]   [Full Text] [Related]  

  • 13. Neonatal serologic screening and early treatment for congenital Toxoplasma gondii infection. The New England Regional Toxoplasma Working Group.
    Guerina NG; Hsu HW; Meissner HC; Maguire JH; Lynfield R; Stechenberg B; Abroms I; Pasternack MS; Hoff R; Eaton RB
    N Engl J Med; 1994 Jun; 330(26):1858-63. PubMed ID: 7818637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term ocular outcome in congenital toxoplasmosis: a prospective cohort of treated children.
    Faucher B; Garcia-Meric P; Franck J; Minodier P; Francois P; Gonnet S; L'ollivier C; Piarroux R
    J Infect; 2012 Jan; 64(1):104-9. PubMed ID: 22051915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. First case of congenital toxoplasmosis from Nepal.
    Rai SK; Sharma A; Shrestha RK; Pradhan P
    Nepal Med Coll J; 2011 Mar; 13(1):64-6. PubMed ID: 21991707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term impact of treated congenital toxoplasmosis on quality of life and visual performance.
    Peyron F; Garweg JG; Wallon M; Descloux E; Rolland M; Barth J
    Pediatr Infect Dis J; 2011 Jul; 30(7):597-600. PubMed ID: 21278618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Congenital toxoplasmosis following infection occurring late in pregnancy].
    Ben Abdallah R; Siala E; Maatoug R; Souissi O; Aoun K; Bouratbine A
    Arch Pediatr; 2011 Jul; 18(7):758-60. PubMed ID: 21632221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effects of combined treatment of infantile toxoplasmosis with pyrimethamine (daraprim) and sulfonamides on the blood and bone marrow].
    Weissbach G
    Z Arztl Fortbild (Jena); 1965 Jan; 59(1):10-22. PubMed ID: 5885819
    [No Abstract]   [Full Text] [Related]  

  • 19. Research on congenital toxoplasmosis.
    Panaitescu D; Steriu D; Stefănoiu V; Pop M
    Roum Arch Microbiol Immunol; 1995; 54(4):313-24. PubMed ID: 8993124
    [No Abstract]   [Full Text] [Related]  

  • 20. [Postnatal therapy for congenital toxoplasmosis: a comparison of 2 different treatment approaches].
    Pohl-Schickinger A; Feiterna-Sperling C; Weizsäcker K; Bührer C
    Z Geburtshilfe Neonatol; 2012 Apr; 216(2):73-6. PubMed ID: 22517047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.